Pharmaceutical CRM Software Market Size, Trends and Insights By Deployment Type (On-Premises CRM Software, Cloud-Based CRM Software), By Application (Customer Relationship Management, Sales Force Automation, Marketing Automation, Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations (CROs), Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Veeva Systems Inc.
- IQVIA Holdings Inc.
- com Inc.
- Cegedim SA
- Syneos Health Inc.
- SAP SE
- Pegasystems Inc.
- Others
Reports Description
As per the current market research conducted by the CMI Team, the global Pharmaceutical CRM Software Market is expected to record a CAGR of 4.8% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 4,356.3 Million. By 2033, the valuation is anticipated to reach USD 6,643.1 Million.
The Pharmaceutical CRM Software Market refers to the global industry focused on providing software solutions tailored to the specific needs of pharmaceutical companies for customer relationship management (CRM). These software solutions enable pharmaceutical companies to effectively manage interactions with healthcare professionals (HCPs), track sales activities, and optimize marketing strategies.
With features such as real-time data analytics, personalized engagement tools, and compliance management capabilities, Pharmaceutical CRM Software empowers companies to enhance customer engagement, improve sales force effectiveness, and drive business growth in the highly regulated and competitive pharmaceutical industry landscape.
Pharmaceutical CRM Software Market – Significant Growth Factors
The Pharmaceutical CRM Software Market presents significant growth opportunities due to several factors:
- Regulatory Compliance Requirements: Stringent regulations in the pharmaceutical industry drive the adoption of CRM software to ensure compliance with laws such as the Sunshine Act and GDPR, fueling the market growth.
- Focus on Customer Relationship Management: The increasing emphasis on building and maintaining relationships with healthcare professionals (HCPs) drives demand for CRM software to track interactions, personalize communications, and enhance customer satisfaction.
- Technological Advancements: Continuous innovation in CRM software, including features like artificial intelligence and predictive analytics, enhances functionality and drives adoption among pharmaceutical companies.
- Growing Digitalization of Healthcare: The digital transformation of the healthcare industry drives the adoption of CRM software for digital marketing, virtual detailing, and telemedicine, supporting market growth.
- Expansion into Emerging Markets: Opportunities exist to expand CRM software offerings into emerging markets, where pharmaceutical companies are increasingly investing in digital solutions to improve commercial operations and customer engagement.
- Integration with Healthcare Ecosystem: There is an opportunity to integrate CRM software with other healthcare systems and platforms, such as electronic health records (EHRs) and telehealth platforms, to create comprehensive solutions that streamline workflows and enhance patient care.
Pharmaceutical CRM Software Market – Mergers and Acquisitions
The Pharmaceutical CRM Software Market has seen several mergers and acquisitions in recent years, with companies seeking to expand their market presence and leverage synergies to improve their product offerings and profitability. Some notable examples of mergers and acquisitions in the Pharmaceutical CRM Software Market include:
- In 2023, Salesforce introduced HIPAA-compliant features in its Commerce Cloud, enhancing healthcare commerce experiences and lowering service costs. Integrated with the Data Cloud, it enables personalized experiences by offering real-time insights into patients and providers across all touchpoints.
- In 2022, QPharma introduced Ti CRM, a rapid implementation CRM solution for pharmaceutical representatives. Ti CRM 2.0 represents the next generation of QPharma’s popular application, enabling thousands of Pharma reps to efficiently capture healthcare professionals’ sample requests while ensuring compliance with regulatory guidelines.
These mergers and acquisitions helped companies expand their product offerings, improve their market presence, and capitalize on growth opportunities in the Pharmaceutical CRM Software Market. The trend is expected to continue as companies seek to gain a competitive edge in the market.
COMPARATIVE ANALYSIS OF THE RELATED MARKET
| Pharmaceutical CRM Software Market | Telehealth Kiosk Market | Digital Health Market |
| CAGR 4.8% (Approx) | CAGR 18.7% (Approx) | CAGR 15.3% (Approx) |
| USD 6,643.1 Million by 2033 | USD 947.6 Million by 2033 | USD 25.8 Billion by 2033 |
Pharmaceutical CRM Software Market – Significant Threats
The Pharmaceutical CRM Software Market faces several significant threats that could impact its growth and profitability in the future. Some of these threats include:
- Data Security and Privacy Concerns: The storage and management of sensitive healthcare data in CRM software pose risks of data breaches and privacy violations, leading to regulatory fines, legal liabilities, and reputational damage for pharmaceutical companies.
- Resistance to Adoption: Resistance from healthcare professionals (HCPs) and sales representatives to adopt CRM software due to concerns about increased workload, changes in workflow, and perceived invasion of privacy can hinder market penetration and usage.
- Integration Challenges: Complexities in integrating CRM software with existing systems and platforms within pharmaceutical companies, such as enterprise resource planning (ERP) systems and electronic medical records (EMRs), can lead to interoperability issues and hinder seamless data exchange, impacting the effectiveness of CRM initiatives.
- Competition from In-House Solutions: Pharmaceutical companies may develop in-house CRM solutions or opt for customized software development, posing a threat to third-party CRM software vendors by reducing demand for their off-the-shelf products.
- Regulatory Changes and Compliance Risks: Evolving regulations in the pharmaceutical industry, such as changes in data protection laws and healthcare marketing regulations, can necessitate frequent updates to CRM software and increase compliance risks for companies, leading to additional costs and operational challenges.
Category-Wise Insights:
By Deployment Type
- On-Premises CRM Software: On-premises CRM software is installed and hosted locally on the company’s servers and infrastructure. While offering greater control over data and customization options, it requires significant upfront investment and ongoing maintenance. Trends include the gradual shift towards cloud-based solutions due to their scalability, cost-effectiveness, and accessibility, although some pharmaceutical companies with stringent data security requirements still prefer on-premises deployments.
- Cloud-Based CRM Software: Cloud-based CRM software is hosted on remote servers and accessed through the internet. It offers flexibility, scalability, and cost-effectiveness, as companies pay for usage on a subscription basis. Trends include the adoption of advanced features such as artificial intelligence and predictive analytics for personalized engagement, real-time data insights, and seamless integration with other digital platforms, driving efficiency and innovation in pharmaceutical CRM practices.
By Application
- Customer Relationship Management (CRM): CRM software in the pharmaceutical sector focuses on managing interactions with healthcare professionals (HCPs) and stakeholders, facilitating personalized engagements and improving customer satisfaction. Trends include the integration of AI for predictive analytics, enabling proactive customer engagement, and the adoption of mobile CRM solutions for real-time data access and collaboration.
- Sales Force Automation (SFA): SFA software streamlines sales processes, automating tasks such as lead management, territory planning, and performance tracking for pharmaceutical sales representatives. Trends include the use of data-driven insights for targeted sales strategies and the integration of virtual detailing platforms for remote engagements with HCPs.
- Marketing Automation: Marketing automation software enables pharmaceutical companies to automate marketing campaigns, personalize communications, and track engagement metrics across various channels. Trends include the incorporation of omnichannel marketing strategies for seamless customer experiences and the use of AI-powered tools for predictive analytics and dynamic content optimization.
- Others: This category encompasses additional applications of CRM software in the pharmaceutical industry, such as compliance management, adverse event reporting, and patient support programs. Trends include the development of specialized modules for regulatory compliance, patient engagement, and pharmacovigilance, addressing unique challenges and requirements within the pharmaceutical ecosystem.
By End User
- Pharmaceutical Companies: Pharmaceutical CRM Software assists these entities in managing customer relationships, tracking sales activities, and ensuring compliance with regulatory standards. Trends include the integration of AI for predictive analytics, personalized marketing strategies, and remote detailing to engage healthcare professionals effectively.
- Biotechnology Companies: Biotech firms utilize CRM Software to streamline sales processes, enhance customer engagement, and facilitate collaboration with research partners. Trends include the adoption of cloud-based solutions for data accessibility and real-time collaboration, and the integration of CRM with laboratory information management systems (LIMS) for seamless data exchange.
- Contract Research Organizations (CROs): CRM Software enables CROs to manage client relationships, track project progress, and optimize resource allocation. Trends include the incorporation of project management features for efficient trial management, integration with electronic data capture (EDC) systems for seamless data collection, and customization capabilities to meet diverse client needs.
- Others: Other end users, such as medical device manufacturers and healthcare service providers, leverage CRM Software to enhance customer engagement and streamline commercial operations. Trends include the adoption of mobile CRM applications for field sales representatives, integration with customer service platforms for efficient issue resolution, and the incorporation of patient relationship management functionalities to support patient-centric care delivery.
Report Scope
| Feature of the Report | Details |
| Market Size in 2024 | USD 4,356.3 Million |
| Projected Market Size in 2033 | USD 6,643.1 Million |
| Market Size in 2023 | USD 4,156.8 Million |
| CAGR Growth Rate | 4.8% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Deployment Type, Application, End-User and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Pharmaceutical CRM Software Market – Regional Analysis
The Pharmaceutical CRM Software Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region:
- North America: In North America, the trend in the Pharmaceutical CRM Software Market leans towards the adoption of advanced analytics and artificial intelligence (AI) for predictive insights and personalized marketing strategies. Additionally, there is a focus on compliance with stringent regulatory requirements such as HIPAA and the Sunshine Act, driving the demand for CRM solutions with robust compliance features.
- Europe: In Europe, the trend revolves around the integration of CRM software with electronic health record (EHR) systems and telemedicine platforms to support remote patient engagement and virtual detailing. Moreover, there is a growing emphasis on data protection and privacy compliance, leading to increased demand for CRM solutions with GDPR-compliant features and secure data storage capabilities.
- Asia-Pacific: In the Asia-Pacific region, the trend is towards the localization of CRM software to cater to diverse regulatory environments and language preferences across countries. Additionally, there is a growing adoption of mobile CRM applications to facilitate remote sales activities and customer interactions in geographically dispersed markets. Furthermore, the increasing investment in healthcare digitalization drives the adoption of CRM solutions for patient relationship management and healthcare analytics.
- LAMEA (Latin America, Middle East & Africa): In LAMEA, the trend is towards the adoption of cloud-based CRM solutions to overcome infrastructure limitations and enhance scalability. There is also a focus on leveraging CRM software for pharmaceutical market access strategies, including payer relationship management and pricing optimization. Additionally, there is a growing demand for CRM solutions with multilingual capabilities to support communication with diverse stakeholders in the region.
Competitive Landscape – Pharmaceutical CRM Software Market
The Pharmaceutical CRM Software Market is highly competitive, with a large number of manufacturers and retailers operating globally. Some of the key players in the market include:
- Veeva Systems Inc.
- IQVIA Holdings Inc.
- com Inc.
- Cegedim SA
- Syneos Health Inc.
- SAP SE
- Pegasystems Inc.
- Oracle Corporation
- Zoho Corporation Pvt. Ltd.
- Bpm’online
- Aktana Inc.
- Insightly Inc.
- Anthill CRM
- Medismo Technologies Pvt. Ltd.
- Indegene Inc.
- Others
These companies operate in the market through various strategies such as product innovation, mergers and acquisitions, and partnerships.
Several new players have entered the Pharmaceutical CRM Software Market with innovative solutions tailored to the evolving needs of pharmaceutical companies. Companies like Aktana and Anthill CRM have introduced advanced features such as AI-driven predictive analytics and real-time data visualization to enhance customer engagement and sales effectiveness.
However, key players such as Veeva Systems and IQVIA Holdings dominate the market with their comprehensive CRM platforms, extensive industry experience, and established customer base. These market leaders leverage their brand reputation and strategic partnerships to maintain a competitive edge and drive market growth.
The Pharmaceutical CRM Software Market is segmented as follows:
By Deployment Type
- On-Premises CRM Software
- Cloud-Based CRM Software
By Application
- Customer Relationship Management
- Sales Force Automation
- Marketing Automation
- Others
By End-User
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Pharmaceutical CRM Software Market, (2024 – 2033) (USD Million)
- 2.2 Global Pharmaceutical CRM Software Market: snapshot
- Chapter 3. Global Pharmaceutical CRM Software Market – Industry Analysis
- 3.1 Pharmaceutical CRM Software Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Regulatory Compliance Requirements
- 3.2.2 Focus on Customer Relationship Management
- 3.2.3 Technological Advancements
- 3.2.4 Growing Digitalization of Healthcare
- 3.2.5 Expansion into Emerging Markets
- 3.2.6 Integration with Healthcare Ecosystem.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Deployment Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End-User
- Chapter 4. Global Pharmaceutical CRM Software Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pharmaceutical CRM Software Market: Company Market Share, 2023
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pharmaceutical CRM Software Market – Deployment Type Analysis
- 5.1 Global Pharmaceutical CRM Software Market Overview: By Deployment Type
- 5.1.1 Global Pharmaceutical CRM Software Market Share, By Deployment Type, 2023 and 2033
- 5.2 On-Premises CRM Software
- 5.2.1 Global Pharmaceutical CRM Software Market by On-Premises CRM Software, 2024 – 2033 (USD Million)
- 5.3 Cloud-Based CRM Software
- 5.3.1 Global Pharmaceutical CRM Software Market by Cloud-Based CRM Software, 2024 – 2033 (USD Million)
- 5.1 Global Pharmaceutical CRM Software Market Overview: By Deployment Type
- Chapter 6. Global Pharmaceutical CRM Software Market – Application Analysis
- 6.1 Global Pharmaceutical CRM Software Market Overview: By Application
- 6.1.1 Global Pharmaceutical CRM Software Market Share, By Application, 2023 and 2033
- 6.2 Customer Relationship Management
- 6.2.1 Global Pharmaceutical CRM Software Market by Customer Relationship Management, 2024 – 2033 (USD Million)
- 6.3 Sales Force Automation
- 6.3.1 Global Pharmaceutical CRM Software Market by Sales Force Automation, 2024 – 2033 (USD Million)
- 6.4 Marketing Automation
- 6.4.1 Global Pharmaceutical CRM Software Market by Marketing Automation, 2024 – 2033 (USD Million)
- 6.5 Others
- 6.5.1 Global Pharmaceutical CRM Software Market by Others, 2024 – 2033 (USD Million)
- 6.1 Global Pharmaceutical CRM Software Market Overview: By Application
- Chapter 7. Global Pharmaceutical CRM Software Market – End-User Analysis
- 7.1 Global Pharmaceutical CRM Software Market Overview: By End-User
- 7.1.1 Global Pharmaceutical CRM Software Market Share, By End-User, 2023 and 2033
- 7.2 Pharmaceutical Companies
- 7.2.1 Global Pharmaceutical CRM Software Market by Pharmaceutical Companies, 2024 – 2033 (USD Million)
- 7.3 Biotechnology Companies
- 7.3.1 Global Pharmaceutical CRM Software Market by Biotechnology Companies, 2024 – 2033 (USD Million)
- 7.4 Contract Research Organizations (CROs)
- 7.4.1 Global Pharmaceutical CRM Software Market by Contract Research Organizations (CROs), 2024 – 2033 (USD Million)
- 7.5 Others
- 7.5.1 Global Pharmaceutical CRM Software Market by Others, 2024 – 2033 (USD Million)
- 7.1 Global Pharmaceutical CRM Software Market Overview: By End-User
- Chapter 8. Pharmaceutical CRM Software Market – Regional Analysis
- 8.1 Global Pharmaceutical CRM Software Market Regional Overview
- 8.2 Global Pharmaceutical CRM Software Market Share, by Region, 2023 & 2033 (USD Million)
- 8.3. North America
- 8.3.1 North America Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.3.1.1 North America Pharmaceutical CRM Software Market, by Country, 2024 – 2033 (USD Million)
- 8.3.1 North America Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.4 North America Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033
- 8.4.1 North America Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033 (USD Million)
- 8.5 North America Pharmaceutical CRM Software Market, by Application, 2024 – 2033
- 8.5.1 North America Pharmaceutical CRM Software Market, by Application, 2024 – 2033 (USD Million)
- 8.6 North America Pharmaceutical CRM Software Market, by End-User, 2024 – 2033
- 8.6.1 North America Pharmaceutical CRM Software Market, by End-User, 2024 – 2033 (USD Million)
- 8.7. Europe
- 8.7.1 Europe Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.7.1.1 Europe Pharmaceutical CRM Software Market, by Country, 2024 – 2033 (USD Million)
- 8.7.1 Europe Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.8 Europe Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033
- 8.8.1 Europe Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033 (USD Million)
- 8.9 Europe Pharmaceutical CRM Software Market, by Application, 2024 – 2033
- 8.9.1 Europe Pharmaceutical CRM Software Market, by Application, 2024 – 2033 (USD Million)
- 8.10 Europe Pharmaceutical CRM Software Market, by End-User, 2024 – 2033
- 8.10.1 Europe Pharmaceutical CRM Software Market, by End-User, 2024 – 2033 (USD Million)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.11.1.1 Asia Pacific Pharmaceutical CRM Software Market, by Country, 2024 – 2033 (USD Million)
- 8.11.1 Asia Pacific Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.12 Asia Pacific Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033
- 8.12.1 Asia Pacific Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033 (USD Million)
- 8.13 Asia Pacific Pharmaceutical CRM Software Market, by Application, 2024 – 2033
- 8.13.1 Asia Pacific Pharmaceutical CRM Software Market, by Application, 2024 – 2033 (USD Million)
- 8.14 Asia Pacific Pharmaceutical CRM Software Market, by End-User, 2024 – 2033
- 8.14.1 Asia Pacific Pharmaceutical CRM Software Market, by End-User, 2024 – 2033 (USD Million)
- 8.15. Latin America
- 8.15.1 Latin America Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.15.1.1 Latin America Pharmaceutical CRM Software Market, by Country, 2024 – 2033 (USD Million)
- 8.15.1 Latin America Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.16 Latin America Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033
- 8.16.1 Latin America Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033 (USD Million)
- 8.17 Latin America Pharmaceutical CRM Software Market, by Application, 2024 – 2033
- 8.17.1 Latin America Pharmaceutical CRM Software Market, by Application, 2024 – 2033 (USD Million)
- 8.18 Latin America Pharmaceutical CRM Software Market, by End-User, 2024 – 2033
- 8.18.1 Latin America Pharmaceutical CRM Software Market, by End-User, 2024 – 2033 (USD Million)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.19.1.1 The Middle-East and Africa Pharmaceutical CRM Software Market, by Country, 2024 – 2033 (USD Million)
- 8.19.1 The Middle-East and Africa Pharmaceutical CRM Software Market, 2024 – 2033 (USD Million)
- 8.20 The Middle-East and Africa Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033
- 8.20.1 The Middle-East and Africa Pharmaceutical CRM Software Market, by Deployment Type, 2024 – 2033 (USD Million)
- 8.21 The Middle-East and Africa Pharmaceutical CRM Software Market, by Application, 2024 – 2033
- 8.21.1 The Middle-East and Africa Pharmaceutical CRM Software Market, by Application, 2024 – 2033 (USD Million)
- 8.22 The Middle-East and Africa Pharmaceutical CRM Software Market, by End-User, 2024 – 2033
- 8.22.1 The Middle-East and Africa Pharmaceutical CRM Software Market, by End-User, 2024 – 2033 (USD Million)
- Chapter 9. Company Profiles
- 9.1 Veeva Systems Inc.
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 IQVIA Holdings Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Salesforce.com Inc.
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 Cegedim SA
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 Syneos Health Inc.
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 SAP SE
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Pegasystems Inc.
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.8 Oracle Corporation
- 9.8.1 Overview
- 9.8.2 Financials
- 9.8.3 Product Portfolio
- 9.8.4 Business Strategy
- 9.8.5 Recent Developments
- 9.9 Zoho Corporation Pvt. Ltd.
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 Bpm’online
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Aktana Inc.
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 Insightly Inc.
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 Anthill CRM
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Medismo Technologies Pvt. Ltd.
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Indegene Inc.
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 Others.
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.1 Veeva Systems Inc.
List Of Figures
Figures No 1 to 26
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2033
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- Veeva Systems Inc.
- IQVIA Holdings Inc.
- com Inc.
- Cegedim SA
- Syneos Health Inc.
- SAP SE
- Pegasystems Inc.
- Oracle Corporation
- Zoho Corporation Pvt. Ltd.
- Bpm’online
- Aktana Inc.
- Insightly Inc.
- Anthill CRM
- Medismo Technologies Pvt. Ltd.
- Indegene Inc.
- Others
FAQs
The key factors driving the Market are Regulatory Compliance Requirements, Focus on Customer Relationship Management, Technological Advancements, Growing Digitalization of Healthcare, Expansion into Emerging Markets, Integration with Healthcare Ecosystem.
The “Customer Relationship Management” had the largest share in the global market for Pharmaceutical CRM Software.
The “On-Premises CRM Software” category dominated the market in 2023.
The key players in the market are Veeva Systems Inc., IQVIA Holdings Inc., Salesforce.com Inc., Cegedim SA, Syneos Health Inc., SAP SE, Pegasystems Inc., Oracle Corporation, Zoho Corporation Pvt. Ltd., Bpm’online, Aktana Inc., Insightly Inc., Anthill CRM, Medismo Technologies Pvt. Ltd., Indegene Inc., Others.
“North America” had the largest share in the Pharmaceutical CRM Software Market.
The global market is projected to grow at a CAGR of 4.8% during the forecast period, 2024-2033.
The Pharmaceutical CRM Software Market size was valued at USD 4,356.3 Million in 2024.